Abstract:Our previous study showed that hypermethylation of dimethylarginine dimethylaminohydrolase 2 contributes to homocysteine-induced apoptosis of human umbilical vein endothelial cells. Epigallocatechin-3-gallate is a green tea-derived phenol which has been proved beneficial on atherosclerosis. It was demonstrated that epigallocatechin-3-gallate inhibits DNA methyltransferase activity and reactivates methylation-silenced genes in cancer cells. The aim of this study was to address whether epigallocatechin-3-gallate could induce DNA demethylation of the dimethylarginine dimethylaminohydrolase 2 gene, contributing to prevent endothelial cells from apoptosis induced by homocysteine. Human umbilical vein endothelial cells (ATCC, CRL-2480) were treated with homocysteine (1 mM) for 48 hours with or without epigallocatechin-3-gallate (20 µM) or 5-Aza (DNA methyltransferase inhibitor, 5 µM). Apoptosis rate of human umbilical vein endothelial cells was assayed by flow cytometry with an annexin V-FITC apoptosis detection kit. The mRNA and protein expression level of dimethylarginine dimethylaminohydrolase 2 and DNA methyltransferase 1 were detected by real-time PCR and Western blot, respectively. DNA methylation level of dimethylarginine dimethylaminohydrolase 2 was assayed by methylation specific PCR. The binding level of DNA methyltransferase 1 in the promoter of dimethylarginine dimethylaminohydrolase 2 was determined by chromatin immunoprecipitation-quantitative real-time PCR. It was shown that the apoptosis rate was decreased significantly in human umbilical vein endothelial cells treated with homocysteine compared with the control. Furthermore, the mRNA and protein level of dimethylarginine dimethylaminohydrolase 2 were downregulated, the dimethylarginine dimethylaminohydrolase 2 gene promoter was hypermethylated, and the DNA methyltransferase 1 mRNA and protein level were increased in human umbilical vein endothelial cells treated with homocysteine. Chromatin immunoprecipitation-quantitative real-time PCR revealed that homocysteine-induced binding of DNA methyltransferase 1 to the dimethylarginine dimethylaminohydrolase 2 promoter was increased. Pretreatment with epigallocatechin-3-gallate or 5-Aza inhibited such effects of homocysteine. In conclusion, epigallocatechin-3-gallate exerted protective effects on homocysteine-induced apoptosis in human umbilical vein endothelial cells by inhibiting promoter hypermethylation of the dimethylarginine dimethylaminohydrolase 2 gene and inducing dimethylarginine dimethylaminohydrolase 2 expression. These effects may be due to the decreased DNA methyltransferase 1 expression and binding of DNA methyltransferase 1 to the dimethylarginine dimethylaminohydrolase 2 promoter induced by epigallocatechin-3-gallate. This research suggests that modulating the epigenetic processes might be a novel plausible way for treatment of atherosclerosis.

Relationship of Impairment Induced by Intracellular S-Adenosylhomocysteine Accumulation with Dna Methylation in Human Umbilical Vein Endothelial Cells Treated with 3-Deazaadenosine

THE RELATIONSHIP OF INCREASED INTRACELLULAR S-ADENOSYLHOMOCYSTEINE WITH HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS DAMAGE AND THE WHOLE DNA METHYLATION

RELATIONSHIP OF INCREASED INTRACELLULAR S-ADENOSYLHOMOCYSTEINE WITH MONOCYTE CHEMOATTRACTANT PROTEIN -1 EXPRESSION IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS

Homocysteine-mediated Expression of SAHH, DNMTs, MBD2, and DNA Hypomethylation Potential Pathogenic Mechanism in VSMCs.

Effect of S-adenosylhomocysteine on Inhibitory Proliferation Induced by ER-α Expression in Endothelial Cells

Homocysteine-induced Hypermethylation of DDAH2 Promoter Contributes to Apoptosis of Endothelial Cells.

Dysfunction Of Endothelial No System Originated From Homocysteine-Induced Aberrant Methylation Pattern In Promoter Region Of Ddah2 Gene

Inhibition of S-Adenosylhomocysteine Hydrolase Induces Endothelial Dysfunction Via Epigenetic Regulation of P66shc-Mediated Oxidative Stress Pathway

Hypermethylation of DDAH2 Promoter Contributes to the Dysfunction of Endothelial Progenitor Cells in Coronary Artery Disease Patients

Hyperhomocysteinemia-mediated DNA Hypomethylation and Its Potential Epigenetic Role in Rats.

Homocysteine-Mediated Ppar Alpha,Gamma Dna Methylation and Its Potential Pathogenic Mechanism in Monocytes

Extracellular-superoxide dismutase DNA methylation promotes oxidative stress in homocysteine-induced atherosclerosis

Methylation and transcriptomic expression profiles of HUVEC in the oxygen and glucose deprivation model and its clinical implications in AMI patients

Role of DNA Methylation in Ischemic-Hypoxic Endothelial Cells and its Clinical Implications in AMI Patients

Homocysteine induces vascular inflammatory response via SMAD7 hypermethylation in human umbilical vein smooth muscle cells

Genome-wide analysis of DNA methylation and its relationship with serum homocysteine levels in patients with hypertension.

Epigallocatechin-3-gallate inhibits homocysteine-induced apoptosis of endothelial cells by demethylation of the DDAH2 gene.

The Comprehensive Effects of Hyperlipidemia and Hyperhomocysteinemia on Pathogenesis of Atherosclerosis and Dna Hypomethylation in Apoe(-/-) Mice

Different effects of homocysteine and oxidized low density lipoprotein on methylation status in the promoter region of the estrogen receptor alpha gene

Global DNA methylation and extracellular matrix remodeling in aortic smooth muscle versus endothelial cells in hyperhomocysteinemia (1120.5)

Increased Plasma S-adenosyl-homocysteine Levels Induce the Proliferation and Migration of VSMCs Through an Oxidative Stress-Erk1/2 Pathway in Apoe(-/-) Mice.